146 related articles for article (PubMed ID: 23469954)
1. Functional effects of levosimendan in rat basilar arteries in vitro.
Konczalla J; Mrosek J; Wanderer S; Schuss P; Guresir E; Seifert V; Vatter H; Platz J
Curr Neurovasc Res; 2013 May; 10(2):126-33. PubMed ID: 23469954
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?
Konczalla J; Wanderer S; Mrosek J; Gueresir E; Schuss P; Platz J; Seifert V; Vatter H
Acta Neurochir (Wien); 2016 Nov; 158(11):2075-2083. PubMed ID: 27614436
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan Reduces Prostaglandin F2a-dependent Vasoconstriction in Physiological Vessels and After Experimentally Induced Subarachnoid Hemorrhage.
Wanderer S; Mrosek J; Gessler F; Seifert V; Konczalla J
Curr Neurovasc Res; 2018; 15(1):72-80. PubMed ID: 29595109
[TBL] [Abstract][Full Text] [Related]
4. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties.
Gruhn N; Nielsen-Kudsk JE; Theilgaard S; Bang L; Olesen SP; Aldershvile J
J Cardiovasc Pharmacol; 1998 May; 31(5):741-9. PubMed ID: 9593074
[TBL] [Abstract][Full Text] [Related]
5. Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery.
Pataricza J; Krassói I; Höhn J; Kun A; Papp JG
Cardiovasc Drugs Ther; 2003 Mar; 17(2):115-21. PubMed ID: 12975592
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
Kivikko M; Lehtonen L
Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
[TBL] [Abstract][Full Text] [Related]
7. The vasodilatory effects of levosimendan on the human internal mammary artery.
Montes FR; Echeverri D; Buitrago L; Ramírez I; Giraldo JC; Maldonado JD; Umaña JP
Anesth Analg; 2006 Nov; 103(5):1094-8. PubMed ID: 17056938
[TBL] [Abstract][Full Text] [Related]
8. Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury.
Boost KA; Hoegl S; Dolfen A; Czerwonka H; Scheiermann P; Zwissler B; Hofstetter C
Crit Care Med; 2008 Jun; 36(6):1873-9. PubMed ID: 18496375
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the cerebrovascular function of endothelin B receptor after subarachnoidal hemorrhage in the rat.
Konczalla J; Vatter H; Weidauer S; Raabe A; Seifert V
Exp Biol Med (Maywood); 2006 Jun; 231(6):1064-8. PubMed ID: 16741050
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm. Part II: effect on endothelin(B) receptor-mediated relaxation.
Vatter H; Zimmermann M; Tesanovic V; Raabe A; Seifert V; Schilling L
J Neurosurg; 2005 Jun; 102(6):1108-14. PubMed ID: 16028771
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between the angiotensin and endothelin-system in the cerebrovasculature.
Konczalla J; Wanderer S; Mrosek J; Schuss P; Platz J; Güresir E; Seifert V; Vatter H
Curr Neurovasc Res; 2013 Nov; 10(4):335-45. PubMed ID: 23988026
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan attenuates pulmonary vascular remodeling.
Revermann M; Schloss M; Mieth A; Babelova A; Schröder K; Neofitidou S; Buerkl J; Kirschning T; Schermuly RT; Hofstetter C; Brandes RP
Intensive Care Med; 2011 Aug; 37(8):1368-77. PubMed ID: 21626431
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels.
Kaheinen P; Pollesello P; Levijoki J; Haikala H
J Cardiovasc Pharmacol; 2001 Apr; 37(4):367-74. PubMed ID: 11300649
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.
Wanderer S; Mrosek J; Vatter H; Seifert V; Konczalla J
Neurosurg Rev; 2018 Apr; 41(2):539-548. PubMed ID: 28756589
[TBL] [Abstract][Full Text] [Related]
15. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin.
Ito Y; Isotani E; Mizuno Y; Azuma H; Hirakawa K
J Cardiovasc Pharmacol; 2000 Jan; 35(1):45-50. PubMed ID: 10630732
[TBL] [Abstract][Full Text] [Related]
16. Calcium-dependent vasorelaxant capacity of levosimendan in porcine and human epicardial coronary artery preparations.
Krassói I; Pataricza J; Kun A; Papp JG
Cardiovasc Drugs Ther; 2000 Dec; 14(6):691-3. PubMed ID: 11300371
[No Abstract] [Full Text] [Related]
17. Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig.
Grossini E; Caimmi PP; Molinari C; Teodori G; Vacca G
J Cardiovasc Pharmacol; 2005 Sep; 46(3):333-42. PubMed ID: 16116339
[TBL] [Abstract][Full Text] [Related]
18. Potassium channel-related relaxation by levosimendan in the human internal mammary artery.
Yildiz O; Seyrek M; Yildirim V; Demirkilic U; Nacitarhan C
Ann Thorac Surg; 2006 May; 81(5):1715-9. PubMed ID: 16631661
[TBL] [Abstract][Full Text] [Related]
19. Vasodilating mechanisms of levosimendan: involvement of K+ channels.
Yildiz O
J Pharmacol Sci; 2007 May; 104(1):1-5. PubMed ID: 17452812
[TBL] [Abstract][Full Text] [Related]
20. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
